Xinnate is awarded prestigious grant from the US Department of Defense (DoD) of 1,77M USD over three years. The grant was issued by US Army Medical Research Acquisition Activity (USAMRAA) and will be used for development of a BioC based formulation in the project entitled ”Prevention and Treatment of Infection and Inflammation in Pressure Ulcers”. The project will run in parallel with the clinical work on acute wounds.
Martin Malmsten, Professor in Biopharmaceuticals, Biophysics and Drug Delivery at the University of Copenhagen and the Director of LEO Foundation Center for Cutaneous Drug Delivery, has taken on the role as Sr advisor and will support the project.